Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.370
-0.060 (-4.20%)
At close: Jul 16, 2026, 4:00 PM EDT
1.350
-0.020 (-1.46%)
Pre-market: Jul 17, 2026, 9:17 AM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $463.77 million as of July 17, 2026. Its market cap has increased by 48.42% in one year.
Market Cap
463.77M
Enterprise Value
465.22M
1-Year Change
48.42%
Ranking
Category
Stock Price
$1.37
ChartMarket Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $463.77M, an increase of 1,316.13%. That is a compound annual growth rate of 47.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 463.77M | 10.00% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 512.04M |
| Verastem | 503.52M |
| Rezolute | 495.17M |
| Silence Therapeutics | 493.59M |
| Sagimet Biosciences | 493.40M |
| ProKidney | 483.30M |
| Artiva Biotherapeutics | 481.99M |
| Kyverna Therapeutics | 472.99M |